Minsheng Royal CSI Enterprise Core Competence 50 ETF (560650.SH) Latest Stock News - Major News Analysis - Longbridge

For Institutions
- Corporate Services
- Developers
Download
Help
About

Markets

Information

Affiliate Program

Promotions

EN

English

简体中文

繁體中文

繁體中文（廣東話）Posts & comments will be shown in Cantonese

Search...

Quote List Quote List

© 2025 Longbridge｜Disclaimer

Event Tracking

Dec26

Fosun Securities Recommends Fuyao Glass, Expected to Maintain Steady Performance in 2026

08:07

Dec24

Hengrui Medicine’s SHR-A1904 Injection Included in Breakthrough Therapy List

08:56

Hengrui Medicine Subsidiary's SHR-A2102 Receives Clinical Trial Approval from NMPA

08:47

Dec22

Mitsubishi UFJ Increases Stake in Fuyao Glass to 6%

11:27

Dec21

Five Subsidiaries of Hengrui Medicine Receive Approval for Multiple Drug Clinical Trials

11:04

Dec19

Hengrui Pharmaceutical's Subsidiary Obtains Clinical Trial Approval for Leuprorelin Acetate Microspheres Injection

12:01